FER
MOLECULAR TARGETFER tyrosine kinase
FER (FER tyrosine kinase) is targeted by 45 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting FER
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | ibrutinib | 4.86 | 128 |
| 2 | foretinib | 4.34 | 76 |
| 3 | tozasertib | 4.33 | 75 |
| 4 | ceritinib | 4.19 | 65 |
| 5 | bosutinib | 4.08 | 58 |
| 6 | doramapimod | 4.06 | 57 |
| 7 | midostaurin | 3.85 | 46 |
| 8 | brigatinib | 3.81 | 44 |
| 9 | pazopanib | 3.69 | 39 |
| 10 | neratinib | 3.66 | 38 |
| 11 | nintedanib | 3.61 | 36 |
| 12 | pelitinib | 3.50 | 32 |
| 13 | tae 684 | 3.43 | 30 |
| 14 | fedratinib | 3.40 | 29 |
| 15 | gilteritinib | 3.40 | 29 |
| 16 | mln 8054 | 3.33 | 27 |
| 17 | alectinib | 3.18 | 23 |
| 18 | rociletinib | 3.18 | 23 |
| 19 | at 9283 | 3.09 | 21 |
| 20 | lestaurtinib | 3.04 | 20 |
| 21 | pacritinib | 3.04 | 20 |
| 22 | pf 03758309 | 3.00 | 19 |
| 23 | danusertib | 2.94 | 18 |
| 24 | r 406 | 2.83 | 16 |
| 25 | k 252a | 2.83 | 16 |
| 26 | pf 00562271 | 2.77 | 15 |
| 27 | apitolisib | 2.71 | 14 |
| 28 | kw 2449 | 2.64 | 13 |
| 29 | ast 487 | 2.56 | 12 |
| 30 | zotiraciclib | 2.56 | 12 |
| 31 | raf 265 | 2.48 | 11 |
| 32 | defactinib | 2.48 | 11 |
| 33 | mk 5108 | 2.48 | 11 |
| 34 | lorlatinib | 2.48 | 11 |
| 35 | azd 7762 | 2.30 | 9 |
| 36 | bms 754807 | 2.30 | 9 |
| 37 | azd 1480 | 2.30 | 9 |
| 38 | su 014813 | 2.20 | 8 |
| 39 | rebastinib | 2.20 | 8 |
| 40 | asp 3026 | 2.08 | 7 |
| 41 | cep 32496 | 1.95 | 6 |
| 42 | pf 03814735 | 1.79 | 5 |
| 43 | ucn 01 | 1.79 | 5 |
| 44 | Crizotinib | 0.69 | 1 |
| 45 | sp600125 | 0.69 | 1 |
About FER as a Drug Target
FER (FER tyrosine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 45 compounds with documented FER interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
FER inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.